1.Repeated spurious elevation of serum prostate-specific antigen values solved by chemiluminescence analysis: A possible interference by heterophilic antibodies.
Arturo DOMINGUEZ ; Miquel BAYO ; Jesus MUNOZ-RODRIGUEZ ; Jose Antonio BELLIDO ; Jose Maria ABASCAL-JUNQUERA ; Naim HANNAOUI ; Josep Maria BANUS
Korean Journal of Urology 2015;56(11):785-787
Heterophilic antibodies are human immunoglobulins directed against various animal antigens. They can produce false-positive results in the analysis of different tumor markers, including prostate-specific antigen. This interference can lead to misdiagnosis, unnecessary tests, and overtreatment in some cases. We present herein the case of a 52-year-old man with repeated spurious elevation of prostate-specific antigen, reaching levels of 108.7 ng/mL, that were suspected to be caused by heterophilic antibodies. The interference was solved by changing the analysis technique. Real values of prostate-specific antigen were less than 1 ng/mL.
Antibodies, Heterophile/*immunology
;
False Positive Reactions
;
Humans
;
Luminescence
;
Male
;
Middle Aged
;
Prostate-Specific Antigen/*blood
;
Prostatic Neoplasms/blood/*diagnosis/immunology
2.Longevity of Antibodies to Live Orientia tsutsugamushi Inoculated in Sprague Dawley Rats.
Chang Nam AN ; Sungmin KIM ; Song Yong PARK ; Tae Yeon KIM ; Luck Ju BAEK ; Chul Joong KIM ; Kwang Soon SHIN
Journal of the Korean Society of Virology 1998;28(2):193-201
In Sprague Dawley (SD) rats, antibodies against strains of Orinentia tsutsugamushi, Kato, Karp and Gilliam, were produced in order to investigate their longevity and cross-reactivities to their corresponding homologous and heterologous antigens. By immunofluorescence assay (IFA) of IgG and IgM, it was shown that the immunity to the homologous strains persisted at a higher level (longevity of at least 34 weeks with higher IFA titers). On the other hand, the immunity to the heterologous strains persisted at a lower level (longevity of 10 to 34 weeks with lower IFA titers). Since infection with one strain of O. tsutsugamushi does not preclude reinfection with other strains, understanding of the antigenic diversity of O. tsutsugamushi and duration of the immunity to both homologous and heterologous strain is very important in diagnosis of scrub typhus.
Animals
;
Antibodies*
;
Antigenic Variation
;
Antigens, Heterophile
;
Diagnosis
;
Fluorescent Antibody Technique
;
Hand
;
Immunoglobulin G
;
Immunoglobulin M
;
Longevity*
;
Orientia tsutsugamushi*
;
Rats
;
Rats, Sprague-Dawley*
;
Scrub Typhus
3.A hyperthyroid patient with measurable thyroid-stimulating hormone concentration - a trap for the unwary.
Mary Jean TAN ; Florence TAN ; Robert HAWKINS ; Wei-Keat CHEAH ; J J MUKHERJEE
Annals of the Academy of Medicine, Singapore 2006;35(7):500-503
INTRODUCTIONIn a patient with hyperthyroidism, the detection of elevated thyroid hormone concentration with measurable thyroid-stimulating hormone (TSH) value poses considerable diagnostic difficulties.
CLINICAL PICTUREThis 38-year-old lady presented with clinical features of thyrotoxicosis. Her serum free thyroxine concentrations were unequivocally elevated [45 to 82 pmol/L (reference interval, 10 to 20 pmol/L)] but the serum TSH values were persistently within the reference interval [0.49 to 2.48 mIU/L (reference interval, 0.45 to 4.5 mIU/L)].
TREATMENTInvestigations excluded a TSH-secreting pituitary adenoma and a thyroid hormone resistance state and confirmed false elevation in serum TSH concentration due to assay interference from heterophile antibodies. The patient was treated with carbimazole for 18 months.
OUTCOMEThe heterophile antibody-mediated assay interference disappeared 10 months following the initiation of treatment with carbimazole, but returned when the patient relapsed. It disappeared again 2 months after the initiation of treatment.
CONCLUSIONSClinicians should be aware of the potential for interference in immunoassays, and suspect it whenever the test results seem inappropriate to the patient's clinical state. Misinterpretation of test values, arising as a result of assay interference, may lead to misdiagnosis, unnecessary and at times expensive investigations, delay in initiation of treatment and worst of all, the initiation of inappropriate treatment.
Adenoma ; diagnosis ; Adult ; Antibodies, Heterophile ; analysis ; immunology ; Diagnostic Errors ; Female ; Graves Disease ; diagnosis ; Humans ; Immunoassay ; Pituitary Neoplasms ; diagnosis ; Thyrotoxicosis ; blood ; diagnosis ; immunology ; Thyrotropin ; blood ; Thyroxine ; blood
4.Over-expression of heme oxygenase-1 does not protect porcine endothelial cells from human xenoantibodies and complement-mediated lysis.
Chi ZHANG ; Lu WANG ; Shan ZHONG ; Xiao-xiao WANG ; Ying XIANG ; Shi CHEN ; Gang CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(1):102-106
Accommodated organs can survive in the presence of anti-organ antibodies and complement. Heme oxygenase-1 (HO-1) is essential to ensure accommodation in concordant xenotransplant models. However, whether induction of HO-1 over-expression could protect porcine endothelial cells (PECs) against human xenoantibodies and complement-mediated lysis and induce an in vitro accommodation is still unknown. The SV40-immortalized porcine aorta-derived endothelial cell line (iPEC) was pre-incubated with 20, 50, or 80 μmol/L of cobalt-protoporphyrins IX (CoPPIX) for 24 h, and the HO-1 expression in iPECs was analyzed by using Western blotting. CoPPIX-treated or untreated iPECs were incubated with normal human AB sera, and complement-dependent cytotoxicity (CDC) was measured by both flow cytometry and lactate dehydrogenase (LDH) release assay. In vitro treatment with CoPPIX significantly increased the expression of HO-1 in iPECs in a dose-dependent manner. Over-expression of HO-1 was successfully achieved by incubation of iPECs with either 50 or 80 μmol/L of CoPPIX. However, HO-1 over-expression did not show any protective effects on iPECs against normal human sera-mediated cell lysis. In conclusion, induction of HO-1 over-expression alone is not enough to protect PECs from human xenoantibodies and complement-mediated humoral injury. Additionally, use of other protective strategies is needed to achieve accommodation in pig-to-primate xenotransplantation.
Animals
;
Antibodies, Heterophile
;
immunology
;
Cell Line
;
Complement System Proteins
;
immunology
;
Dose-Response Relationship, Drug
;
Endothelial Cells
;
drug effects
;
immunology
;
Heme Oxygenase-1
;
metabolism
;
Humans
;
Protoporphyrins
;
pharmacology
;
Swine
;
Up-Regulation
;
drug effects
5.Mechanism of Humoral and Cellular Immune Modulation Provided by Porcine Sertoli Cells.
Hak Mo LEE ; Byoung Chol OH ; Dong Pyo LIM ; Dong Sup LEE ; Hong Gook LIM ; Chun Soo PARK ; Jeong Ryul LEE
Journal of Korean Medical Science 2008;23(3):514-520
The understanding of main mechanisms that determine the ability of immune privilege related to Sertoli cells (SCs) will provide clues for promoting a local tolerogenic environment. In this study, we evaluated the property of humoral and cellular immune response modulation provided by porcine SCs. Porcine SCs were resistant to human antibody and complement-mediated formation of the membrane attack complex (38.41+/-2.77% vs. 55.02+/-5.44%, p=0.027) and cell lysis (42.95+/-1.75% vs. 87.99 +/-2.25%, p<0.001) compared to immortalized aortic endothelial cells, suggesting that porcine SCs are able to escape cellular lysis associated with complement activation by producing one or more immunoprotective factors that may be capable of inhibiting membrane attack complex formation. On the other hand, porcine SCs and their culture supernatant suppressed the up-regulation of CD40 expression (p<0.05) on DCs in the presence of LPS stimulation. These novel findings, as we know, suggest that immune modulatory effects of porcine SCs in the presence of other antigen can be obtained from the first step of antigen presentation. These might open optimistic perspectives for the use of porcine SCs in tolerance induction eliminating the need for chronic immunosuppressive drugs.
Animals
;
Antibodies, Heterophile/immunology
;
Antibody Formation/*immunology
;
Antigens, CD40/immunology
;
Aorta/cytology
;
Cell Line, Transformed
;
Cell Survival/immunology
;
Complement Membrane Attack Complex/immunology
;
Complement System Proteins/immunology
;
Dendritic Cells/cytology/immunology
;
Endothelial Cells/cytology/immunology
;
Epitopes/immunology
;
Humans
;
Immune Tolerance/*immunology
;
Immunity, Cellular/*immunology
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Sertoli Cells/cytology/*immunology
;
Swine
;
*Tissue Engineering
;
Transplantation, Heterologous